Understand the source comparison
5-Amino-1MQ vs Tesofensine: Which Is Better? | Real Peptides
Research published in 2021 identified NNMT (nicotinamide N-methyltransferase) as a metabolic checkpoint enzyme. Overexpression of NNMT in adipose tissue directly correlates with reduced NAD+ availability, impaired mitochondrial function, and diminished cellula
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Research published in 2021 identified NNMT (nicotinamide N-methyltransferase) as a metabolic checkpoint enzyme. Overexpression of NNMT in adipose tissue directly correlates with reduced NAD+ availability, impaired mitochondrial function, and diminished cellular energy expenditure. 5-Amino-1MQ inhibits this enzyme, forcing cells back into fat oxidation mode. Tesofensine, by contrast, is a triple monoamine reuptake inhibitor originally developed as an antidepressant. It blocks the reuptake of serotonin, norepinephrine, and dopamine in the CNS, creating appetite suppression and increased energy expenditure through entirely different pathways. These compounds don't occupy the same functional category.
- Our team has worked with research-grade peptides for years, and we've seen how often these two are grouped together in weight loss discussions despite having zero mechanistic overlap. The rest of this article breaks down their actual biological targets, clinical trial outcomes, side effect profiles, and which research applications each one genuinely serves.
- What is the difference between 5-Amino-1MQ and tesofensine for weight loss research?
- 5-Amino-1MQ is a small-molecule NNMT inhibitor that increases intracellular NAD+ levels and shifts metabolism toward fat oxidation at the mitochondrial level. Tesofensine is a CNS-active triple monoamine reuptake inhibitor that suppresses appetite by prolonging serotonin, norepinephrine, and dopamine signaling in the brain. One targets cellular energy metabolism directly; the other modulates hunger and satiety through neurotransmitter pathways.
- The 5-amino-1mq vs tesofensine which better comparison hinges on whether the research goal is metabolic reprogramming or appetite modulation. 5-Amino-1MQ doesn't cross the blood-brain barrier in meaningful concentrations. Its effects are peripheral, working inside adipocytes and hepatocytes to restore NAD+-dependent metabolic flexibility. Tesofensine, conversely, is a centrally acting compound with psychoactive properties; it was initially studied as an antidepressant before Phase 2 trials identified significant weight loss as a secondary outcome. This article covers their mechanisms, clinical data, side effect profiles, and which research contexts favour one compound over the other.